¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2023-05-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2023-05-12
±³À°ÀÏÀÚ : 2023-05-12
±³À°Àå¼Ò : ´ë±¸ ÀÎÅͺҰíÈ£ÅÚ ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : 2023³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ¹ÚÀξÆ
¿¬¶ôó : 02-795-3094  

À̸ÞÀÏ : ksphe@kams.or.kr

±³À°Á¾·ù : º´¸®°ú

Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í 1. ¹Ì³³È¸ºñ ¾ø´Â ȸ¿ø : Àü¹®ÀÇ 70,000/±ºÀÇ°ü,Àü°øÀÇ 50,000 2. ¹Ì³³È¸ºñ Àִ ȸ¿ø : Àü¹®ÀÇ 90,000/±ºÀÇ°ü, Àü°øÀÇ 70,000 3. ºñȸ¿ø : Àü¹®ÀÇ 120,000/ À¯°ü¾÷ü¶Ç´Â´Üü¼Ò¼Óºñȸ¿ø 120,000/ Àü°øÀÇ, Á¶±³, ´ëÇпø»ý 70,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ1 08:30~09:00 1. Kidney Tumors (1): Changes in Existing Renal Entities ±è¿µ¾Æ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ1 09:00~09:30 2. Kidney Tumors (2): New and Emerging Renal Entities ÀÌÁ¤Çö(°í·ÁÀÇ´ë)

Åä·Ð 05-12 2Ãþ ÄÁº¥¼ÇȦ1 09:30~09:45 Q&A ()

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ1 09:45~10:15 3. Prostate Tumors À±±æ¼÷(°æºÏÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ1 10:15~10:45 4. Urinary Bladder Tumors À̱Իó(¼­¿ïÀÇ´ë)

Åä·Ð 05-12 2Ãþ ÄÁº¥¼ÇȦ1 10:45~11:00 Q&A ()

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 08:30~09:00 1. Emerging Entities of Sinonasal Tumors À±¼±¿Á(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 09:00~09:30 2. Tumors of the Oral Cavity and Mobile Tongue Á¶ÁØÈÆ(¼º±Õ°üÀÇ´ë)

Åä·Ð 05-12 2Ãþ ÄÁº¥¼ÇȦ2 09:30~09:45 Q&A ()

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 09:45~10:15 3. Salivary Gland Tumor: Part ¥°. Classic Entities °íÁö¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 10:15~10:45 4. Salivary Gland Tumor: Part ¥±. Emerging Entities ¼ÛÁؼ±(¿ï»êÀÇ´ë)

Åä·Ð 05-12 2Ãþ ÄÁº¥¼ÇȦ2 10:45~11:00 Q&A ()

ÈÞ½Ä 05-12 11:00~11:30 Coffee Break ()

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ1 11:30~12:30 Keynote Lecture 3 (Great Collaborators): º´¸®°ú¿Í ÇÔ²² °¡´Â ¾ÏȯÀÚ Áø·áÀÇ ±æ À̼¼ÈÆ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 13:30~13:45 1. Unusual Tumors in Head and Neck ±è¹ÎÁ¾(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 13:45~14:00 2. Suspected Fusion-Driven Sarcoma Masquerading as Angiosarcoma ÇÑÁöÈç(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 14:00~14:15 3. A Rare, Educational Pleural Lesion ±è±Ô¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 14:15~14:30 4. Peculiar Clinicopathologic Features Suggesting a Genetic Cancer Predisposition Syndrome ÀÌÁ¾¿ø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 14:30~14:45 5. Rare Sarcomas with Remarkable Diagnostic or Therapeutic Significance ·ùÇâÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 14:45~15:00 6. A Diagnostically Challenging Liver Tumor Associated with Hereditary Cancer Syndrome ¾Èº¸°æ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 15:00~15:15 7. Surprising Histologic Transformation of a Glioma ¹èÇö½Ä(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05-12 2Ãþ ÄÁº¥¼ÇȦ2 15:15~15:30 8. Cholestatic Liver Function Abnormality in a Patient Who Received Liver Transplantation Due to PFIC Type 2 ¼ÛÀÎÇý(¿ï»êÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2023-05-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŻý¾ÆÇÐȸ Á¦30Â÷ Ãá°èÇмú´ëȸ : 2023-05-12
´ÙÀ½±Û ´ëÇÑ ÇǺΠÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° 2Â÷ : 2023-05-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
825 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø ¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2018 : 2018-10-14 0 867 2018-09-06
824 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-13 0 955 2018-09-06
823 ¼­¿ï °Ç±¹´ëÇб³º´¿ø Á¦9ȸ ±¤Áø,µ¿´ë¹®,¼ºµ¿,Á߶û,Áß±¸ÀÇ»çȸ Çмú´ëȸ : 2018-10-13 0 977 2018-09-06
822 ´ëÀü 2018³â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-13 0 961 2018-09-06
821 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø 2018 ±Ý¿¬¿¬±¸È¸ Á¦4Â÷ ½ÉÆ÷Áö¾ö : 2018-10-13 0 729 2018-09-06
820 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø 2018³â ³»°ú ¿¬¼ö°­Á : 2018-10-13 0 938 2018-09-06
819 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦18ȸ »ï¼ºÈ²¹Ý½ÉÆ÷Áö¿ò : 2018-10-13 0 895 2018-09-06
818 °­¿ø 2018³â ´ëÇÑÃé´ãµµÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-13 0 503 2018-09-06
817 ¼­¿ï ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-10-13 0 633 2018-09-06
816 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø The 6th GSTEC (Gangnam Severance Single Topic Endoscopic Conference) : 2018-10-13 0 579 2018-09-06
815 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-12 0 765 2018-09-06
814 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-12 0 2,685 2018-09-06
813 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2018 International Congress of Diabetes and Metabolism : 2018-10-11 0 649 2018-09-06
812 ¼­¿ï ´ëÇÑÁø´Ü¸é¿ªÇÐȸ Ãß°è½ÉÆ÷Áö¾ö : 2018-10-11 0 492 2018-09-06
811 ºÎ»ê ´ëÇѺñ´¢±â°úÇÐȸ °ú¹Î¼º¹æ±¤ ¾à¹°Ä¡·áÀÇ Çã ¿Í ½Ç : 2018-10-11 0 1,024 2018-09-06
1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷